Rebecca and John Moores UCSD Cancer Center

Thomas J. Kipps, MD, PhD
Januario Castro, MD
University of California,
San Diego
3855 Health Sciences Drive
La Jolla, CA 92093-0820
(858) 822-5635 Phone
(858) 534-5560 fax
(866) 558-7933
http://cancer.ucsd.edu

New Patient Registration

New patients should contact Mary Carpenter at (858) 822-5635 to request an appointment.. Prior to your appointment, you will be contacted in order to review insurance coverage and to obtain additional information. Please have your insurance card and referral information available.

Dr. Thomas J. Kipps

Dr. Kipps is a UCSD Professor of Medicine and Deputy Director of Research at the Moores UCSD Cancer Center. He received his PhD in Immunology and MD from Harvard University, and had his residency and fellowship training in Internal Medicine, Hematology, and Genetics at Stanford University.

Dr. Kipps has a national and international reputation for his work in cancer research, immunology, and gene therapy. He is the author of more than 200 publications and is the primary investigator on several peer-reviewed grants, including an award from NCI/NIH to fund the Chronic Lymphocytic Leukemia Consortium (CRC). The CRC involves collaboration with eight other Cancer Centers around the nation. Dr. Kipps has 20 years of experience in combining research and clinical care responsibilities.

Dr. Januario Castro

Januario E. Castro, M.D. is an Assistant Clinical Professorin the Blood and Marrow Transplantation Division. His main research interest is the study of immune responses against leukemia and lymphoma that can be used for treatment of these clinical conditions. He has found that patients with chronic lymphocytic leukemia (CLL) have a status of immunological anergy that impedes proper antigen presentation and T cells mediated rejection of the leukemia clone(s). He has also observed also that leukemia anergy can be reversed in vitro by activation of CLL B cells via transduction with CD40 ligand (CD154) or by incubation with DNA oligodeoxynucleotides. Currently, Dr. Castro is studying the characteristics of this process in which they break leukemia tolerance and the potential applications in clinical trials.

Dr. Castro completed his Hematology/Oncology fellowship at UCSD, is Board Certified in Internal Medicine and in Hematology and Oncology. He has published four peer reviewed papers, seven abstracts, and seven invited articles, reviews or book chapters.